Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00820781 · ClinicalTrials.gov registry record · NA
Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 518
- Enrollment target
NCT00820781: Completed NA study, sponsored by University of California, San Diego.
NCT00820781 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 518 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00820781, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 518 participants
- Enrollment target
Study Summary
In unselected cirrhotic patients with bleeding gastric varices to compare the influence on mortality rate, duration of life, control of bleeding, quality of life, and economic costs of treatment of: portacaval shunt, endoscopic variceal sclerotherapy and/or variceal ligation.
Interventions
- PROCEDURE Portacaval shunt
- PROCEDURE Sclerotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 518 participants |
| Start Date | 1977-08 |
| Est. Completion | 2003-04 |
| Phase | NA |
What the finished NCT00820781 record still lists
NCT00820781 is an interventional study that assigns participants to a tested intervention. The registered 518 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 2 interventions - of which Portacaval shunt is the first listed.
NCT00820781 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00820781 about?
NCT00820781 is a clinical study titled "Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices". In unselected cirrhotic patients with bleeding gastric varices to compare the influence on mortality rate, duration of life, control of bleeding, quality of life, and economic costs of treatment of: portacaval shunt, endoscopic variceal sclerotherapy and/or variceal ligation.
What is the current status of trial NCT00820781?
This trial is currently completed. It is a NA study. The enrollment target is 518 participants. The study started on 1977-08. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00820781?
The interventions under investigation include: Portacaval shunt (PROCEDURE), Sclerotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT00820781?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00820781's enrollment target sits among peer trials
518 191st of 2000 higher than 1,810 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04524871 · 518 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
- NCT07112196 · 518 participants · Phase 2
Visugromab in Cachexia International Trial
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia